Melissa J. Mendoza, JD U.S. FDA

Melissa Mendoza is the Director of the Office of Compliance and Biologics Quality (OCBQ) in the Center for Biologics Evaluation and Research (CBER) at the U.S. Food and Drug Administration. OCBQ is responsible for ensuring the quality of products regulated by CBER over their entire lifecycle, from pre-market review and inspection to post-market review, surveillance, inspection, outreach, and compliance. Melissa previously served as OCBQ's Deputy Director and as an Associate Chief Counsel for Enforcement in FDA’s Office of the Chief Counsel.